BIOA
BioAge Labs, Inc
NASDAQ: BIOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$16.85
-0.06% today
Updated 2026-04-30
Market cap
$756.98M
P/E ratio
—
P/S ratio
84.16x
EPS (TTM)
$-2.24
Dividend yield
—
52W range
$4 – $24
Volume
0.5M
BioAge Labs, Inc (BIOA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $114.08M | $152.44M | $143.09M | $161.33M | $69.51M | $28.43M | $25.92M | $358.23M |
| Cash & equivalents | $83.73M | $51.04M | $6.97M | $16.16M | $4.63M | $27.64M | $21.64M | $354.35M |
| Current assets | $94.96M | $57.09M | $10.84M | $31.42M | $15.25M | $28.03M | $25.31M | $357.10M |
| Total liabilities | $49.07M | $94.91M | $96.73M | $112.84M | $47.66M | $140.99M | $199.32M | $35.11M |
| Current liabilities | $17.81M | $22.90M | $29.68M | $45.30M | $11.30M | $5.86M | $58.17M | $27.77M |
| Long-term debt | — | — | — | — | — | $2.25M | $8.20M | $2.50M |
| Shareholder equity | $65.01M | $57.53M | $46.36M | $48.49M | $21.85M | $-112.56M | $-173.40M | $323.13M |
| Retained earnings | $-115.04M | $-161.47M | $-198.29M | $-220.77M | $-318.92M | $-117.85M | $-181.70M | $-252.81M |
| Accounts receivable | $754987.00 | $476851.00 | $978634.00 | $986935.00 | $4.86M | — | — | — |
| Inventory | $2.42M | $1.80M | $1.75M | $4.50M | $4.82M | — | — | — |
| Goodwill | $692788.00 | $625364.00 | $625364.00 | $625364.00 | — | — | — | — |